Market Overview

Aptevo Therapeutics Announced Preclinical Data for New Bispecific Antibody Candidates Targeting CD123, CD3 to be Presented at AACR 2017

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News

 

Related Articles (APVO)